BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9499049)

  • 1. Identification of a domain within the human T-cell leukemia virus type 2 envelope required for syncytium induction and replication.
    Poon B; Chen IS
    J Virol; 1998 Mar; 72(3):1959-66. PubMed ID: 9499049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
    Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.
    Rosenberg AR; Delamarre L; Preira A; Dokhélar MC
    J Virol; 1998 Sep; 72(9):7609-14. PubMed ID: 9696862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell leukemia virus type 1 receptor expression among syncytium-resistant cell lines revealed by a novel surface glycoprotein-immunoadhesin.
    Jassal SR; Pöhler RG; Brighty DW
    J Virol; 2001 Sep; 75(17):8317-28. PubMed ID: 11483777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells.
    Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y
    J Virol; 1997 Jan; 71(1):601-7. PubMed ID: 8985389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
    Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
    Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain.
    Kim FJ; Manel N; Boublik Y; Battini JL; Sitbon M
    J Virol; 2003 Jan; 77(2):963-9. PubMed ID: 12502812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: implications for inhibiting viral transmission.
    Daenke S; Booth S
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1731-6. PubMed ID: 11080818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins.
    Berlioz-Torrent C; Shacklett BL; Erdtmann L; Delamarre L; Bouchaert I; Sonigo P; Dokhelar MC; Benarous R
    J Virol; 1999 Feb; 73(2):1350-61. PubMed ID: 9882340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feline leukemia virus envelope sequences that affect T-cell tropism and syncytium formation are not part of known receptor-binding domains.
    Gwynn SR; Hankenson FC; Lauring AS; Rohn JL; Overbaugh J
    J Virol; 2000 Jul; 74(13):5754-61. PubMed ID: 10846053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an 80-kilodalton membrane glycoprotein important for human T-cell leukemia virus type I and type II syncytium formation and infection.
    Agadjanyan MG; Ugen KE; Wang B; Williams WV; Weiner DB
    J Virol; 1994 Jan; 68(1):485-93. PubMed ID: 8254759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.
    Kannian P; Fernandez S; Jones KS; Green PL
    J Virol; 2013 Aug; 87(16):9344-52. PubMed ID: 23785214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding.
    Daenke S; Booth S
    J Cell Sci; 2000 Jan; 113 ( Pt 1)():37-44. PubMed ID: 10591623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies.
    Tallet B; Astier-Gin T; Moynet D; Londos-Gagliardi D; Guillemain B
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):337-48. PubMed ID: 11242520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.
    Pique C; Lagaudrière-Gesbert C; Delamarre L; Rosenberg AR; Conjeaud H; Dokhélar MC
    Virology; 2000 Oct; 276(2):455-65. PubMed ID: 11040136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
    Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
    J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans.
    Piñon JD; Klasse PJ; Jassal SR; Welson S; Weber J; Brighty DW; Sattentau QJ
    J Virol; 2003 Sep; 77(18):9922-30. PubMed ID: 12941902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides.
    Sagara Y; Inoue Y; Shiraki H; Jinno A; Hoshino H; Maeda Y
    J Virol; 1996 Mar; 70(3):1564-9. PubMed ID: 8627675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TM domain swapping of murine leukemia virus and human T-cell leukemia virus envelopes confers different infectious abilities despite similar incorporation into virions.
    Denesvre C; Carrington C; Corbin A; Takeuchi Y; Cosset FL; Schulz T; Sitbon M; Sonigo P
    J Virol; 1996 Jul; 70(7):4380-6. PubMed ID: 8676461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.